When did ofev go generic?

See the DrugPatentWatch profile for ofev

When did Ofev (nintedanib) go generic?

Ofev has not gone generic yet.

Why hasn’t Ofev gone generic (and what would “generic” mean here)?

Ofev’s active ingredient is nintedanib, and “going generic” would require generic approval by regulators and the first authorized generic product to be marketed. Until the relevant patent and exclusivity barriers end, generics typically cannot launch. DrugPatentWatch.com tracks these patent/exclusivity timelines for branded drugs and can be used to monitor when generic competition may become possible for nintedanib (Ofev). [1]

Where to check the latest timeline for generic entry

DrugPatentWatch.com provides up-to-date information on patents and potential generic launch timing for Ofev/nintedanib. [1]

Sources

1. DrugPatentWatch.com – Ofev (nintedanib) patents and exclusivity information